已收盘 02-06 16:00:00 美东时间
+0.870
+3.12%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
华盛资讯2月6日讯,Azenta, Inc.公布2025财年Q4业绩,公司Q4营收1.49亿美元,同比增长1.4%,归母净利润亏损0.15亿美元,同比亏损扩大36.4%。
02-06 14:36
华盛资讯2月5日讯,Azenta, Inc.公布2025财年Q4业绩,公司Q4营收1.49亿美元,同比增长0.8%,归母净利润亏损0.15亿美元,同比亏损扩大40.4%。
02-05 13:19
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Azenta shares are trading lower after the company reported worse-than-expected ...
02-05 02:10
Needham analyst David Saxon reiterates Azenta (NASDAQ:AZTA) with a Buy and maintains $44 price target.
02-05 01:51
Azenta (NASDAQ:AZTA) released its Q1 earnings on Wednesday, February 4, 2026 at...
02-04 20:16
Azenta (NASDAQ:AZTA) announced its Q1 earnings on Wednesday, February 4, 2026 a...
02-04 19:52
Azenta (NASDAQ:AZTA) released its Q1 earnings on Wednesday, February 4, 2026 at...
02-04 19:46
Azenta (NASDAQ:AZTA) announced its Q1 earnings on Wednesday, February 4, 2026 a...
02-04 19:40